ImmunityBio Reports Median Overall Survival Not Yet Reached and Lymphopenia Reversed in Recurrent Glioblastoma Patients Receiving ANKTIVA® Plus CAR-NK, Chemo-Free Therapy

ImmunityBio, Inc. (NASDAQ: IBRX), a commercial-stage immunotherapy company developing cytokine and cellular immunotherapies designed to restore immune competence, today announced updated Phase 2 ...

Quantitative Analysis for Hedge Funds: Measuring Performance & Risk

Discover how quantitative analysis can illuminate hedge fund performance, offering insights into risk metrics and benchmarks ...
Scientific Research Publishing

Galactic Rotation Curves Explained in the 4DEU Framework by 3D Spatial Curvature from Local Gravitational Blocking of Cosmic Expansion: No Need for Dark Matter ()

The observed near flatness of galactic rotation curves has long been interpreted as evidence for large amounts of non-baryonic dark matter. Here we show that this phenom ...
Transformer on MSNOpinion

Against the METR graph

METR’s benchmark has become a bellwether of AI capability growth, but its design isn’t up to the task, argues Nathan Witkin ...